🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
BEAT Tuberculosis is a phase 3, open label, multi-centre, randomized contro...
Status
Completed
Location
Jose Pearson TB Hospital
Start Date
2019-08-22
Trial ID
NCT04062201
The purpose of the study was to evaluate the efficacy (how well the medicin...
Status
Completed
Location
Gaborone CRS (Site ID: 12701)
Start Date
2022-09-27
Trial ID
NCT05007821
This Phase I/II study evaluated the pharmacokinetics, safety, and tolerabil...
Status
Completed
Location
Byramjee Jeejeebhoy Medical College (BJMC) CRS
Start Date
2019-02-18
Trial ID
NCT03141060
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of 26 weeks...
Status
Active Not Recruiting
Location
Gaborone CRS
Start Date
2019-06-03
Trial ID
NCT03568383
Treatments Being Tested
The goal of this clinical trial is to compare the efficacy and safety of a ...
Status
Active Not Recruiting
Location
Beijing Chest Hospital affiliated to Capital Medical University
Start Date
2023-12-22
Trial ID
NCT06081361
The purpose of this study is to determine whether one or two 17-week regime...
Status
Active Not Recruiting
Location
TBTC Site 26 Seattle & King County TB Control Program
Start Date
2023-11-21
Trial ID
NCT05766267
Treatments Being Tested
Multidrug-resistant tuberculosis (MDR-TB) is tuberculosis (TB) that is resi...
Status
Active Not Recruiting
Location
TB-HIV Innovations & Clinical Research Foundation Corp
Start Date
2022-06-07
Trial ID
NCT03828201
Treatments Being Tested
The PRESCIENT trial is a Phase IIc, open-label, randomized trial that compa...
Status
Active Not Recruiting
Location
GHESKIO
Start Date
2023-11-24
Trial ID
NCT05556746
This study aims to compare the efficacy and safety of a 6-month all-oral re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-30
Trial ID
NCT07198685
Treatments Being Tested